Skip to content

Wave Life Sciences WVE Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$124.06M-15.6%
ALN
Alnylam PharmaceuticalsALNY
$189.3M-4.0%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$98.15M-4.0%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$19.65M-17.7%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL

Other financials

Income statement

See full
Revenue$38.2M+317%
Operating income-$31.3M+37.2%
Net income-$26.1M+44.4%
EPS (diluted)-$0.13+55.2%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total debt$15.7M-33.4%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.14B+13.0%
Enterprise value$615.92M-22.3%
P/S15.1×-12.2×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%
Debt / equity-0.1×
Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wave Life Sciences's operating lease ROU assets?
Wave Life Sciences (WVE) reported operating lease ROU assets of $10.99M in Q1 2026.
How has Wave Life Sciences's operating lease ROU assets changed year-over-year?
Wave Life Sciences's operating lease ROU assets decreased by 33.7% year-over-year, from $16.58M to $10.99M.
What is the long-term trend for Wave Life Sciences's operating lease ROU assets?
Over 5 years (2020 to 2025), Wave Life Sciences's operating lease ROU assets has grown at a -5.2% compound annual growth rate (CAGR), from $16.23M to $12.46M.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.